CA
NZ
UK
AU
IND
US
Mirum Pharmaceuticals (NASDAQ:MIRM) rose about 5.2% to USD 85.58 in the October 9, 2026 session, with no catalyst identified, and no company announcement was found for October 8 or 9. Published market data showed a close near USD 81.35 on October 8, which fits …
Humana (NYSE:HUM) gained 12.72%, or USD 49.24, to USD 436.36 in the October 9, 2026 session onVolumeof 2.502 million shares. Published reports tie the move to the 2027 Medicare Advantage Star Ratings, which the Centers for Medicare and Medicaid Services released on Thursday, October …
Novavax (NASDAQ:NVAX) rose 8.99%, or USD 0.99, to USD 12.00 in the October 9, 2026 session onVolumeof 7.623 million shares. A search of company releases and published reports found no announcement dated October 8 or October 9, so there is no company announcement found …
Humana (NYSE:HUM) gained 14.64% to USD 443.78 in the October 9, 2026 session, giving it aMarket Valuenear USD 53.29 billion, according to published market data. Published reports tie the move to the Medicare Advantage Star Ratings for 2027, which the Centers for Medicare and …
Alignment Healthcare (NASDAQ:ALHC) closed the prior session at USD 8.71 and traded at USD 7.15 in the October 9, 2026 session, down 17.91%, for aMarket Valuenear USD 1.48 billion, per published market data. The trigger was the October 8 release of 2027 Medicare Advantage …
● TrailingRevenuewas US$11.37 million, down 28.3 percent, with a net loss of US$6.31 million for 2025.
● Management guides to 12-month response data, a pre-BLA FDA meeting and a BLA submission start in second-half 2026.
● Second-quarter 2026Revenuereached $652.5 million, up from $444.3 million, while the net loss narrowed to $28.4 million.
● Apimeds completed a comparatively small initial public offering and still has a limited public float.
● Caribou’s board approved a plan to discontinue development of two lead allogeneic CAR T programs.
Please wait processing your request...